Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

England's COVID re-opening in doubt as Delta variant spreads

Published 11/06/2021, 08:06
Updated 11/06/2021, 17:03
© Reuters. FILE PHOTO: A dose of AstraZeneca vaccine is prepared at COVID-19 vaccination centre in the Odeon Luxe Cinema in Maidstone, Britain February 10, 2021. REUTERS/Andrew Couldridge/File Photo

By Alistair Smout

LONDON (Reuters) -British Prime Minister Boris Johnson's hopes of ending England's coronavirus lockdown on June 21 hung in the balance on Friday as data showed a further rise in cases of the rapidly spreading Delta variant.

Johnson is due to announce on Monday (NASDAQ:MNDY) whether the planned lifting of restrictions, which would see an end to limits on social contact, can go ahead on time.

But the rapid spread of the Delta variant, officially a "variant of concern", has thrown those plans into jeopardy, prompting speculation that the June 21 date will be pushed back, or that some restrictions will remain.

"We have to be really careful. We had a very big opening on the 17th of May where people could meet friends indoors, in a restaurant, in a pub, and socialise indoors as well," COVID-19 vaccines minister Nadhim Zahawi told Times Radio.

"And I think it's important that we look at the data very carefully over this weekend and then share it with the nation."

Total British cases of the Delta variant, first identified in India, have jumped by 29,892 to 42,323, Public Health England said on Friday, adding that the variant currently accounted for over 90% of new COVID-19 cases.

A top British epidemiologist said on Wednesday that the Delta variant is believed to be 60% more transmissible than the previously dominant Alpha variant. Some scientists have urged a delay to restrictions being eased so more people can receive a second vaccine dose.

A widely watched prevalence survey showed that the number of people with COVID-19 was estimated to have risen in the week to June 5, though not as sharply as the week before.

Britain on Friday reported 8,125 new COVID-19 cases, the highest daily total since February, adding that the reproduction "R" number and daily growth rates were also higher in the latest estimates, suggesting the pandemic was growing exponentially.

© Reuters. FILE PHOTO: A dose of AstraZeneca vaccine is prepared at COVID-19 vaccination centre in the Odeon Luxe Cinema in Maidstone, Britain February 10, 2021. REUTERS/Andrew Couldridge/File Photo

Johnson has said that an increase in cases was always expected after the most recent stage of lockdown easing in May, but the key to whether Step 4 can proceed on June 21 will be the extent to which Britain's vaccine rollout has broken the link between cases and deaths.

Britain's total COVID-19 death toll is over 127,000 but the number of daily deaths have fallen following a third national lockdown and a rapid vaccine rollout. More than three-quarters of adults have received at least one dose of COVID-19 vaccine.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.